natgillin/translations-raw huggingface dataset:
Depending on response and tolerability, Lacosamide Accord 150 mg tablets may be taken twice a day during the third week and Lacosamide Accord 200 mg tablets twice a day during the fourth week.
Ovisno o odgovoru i podnošljivosti, Lakozamid Accord tablete od 150 mg mogu se uzimati dvaput na dan tijekom trećeg tjedna i Lakozamid Accord tablete od 200 mg dvaput na dan tijekom četvrtog tjedna.
This medicinal product contains lecithin (soya).
Ovaj lijek sadrži lecitin (soju).
Hypoesthesia Dysarthria Disturbance in attention Paraesthesia
Hipoestezija Dizartrija Poremećaj pažnje Parestezija
Treatment initiation pack (in adolescent and children weighing 50 kg or more and adults only) Lacosamide Accord 50 mg film-coated tablets
Pakiranje za početak liječenja (samo za adolescente i djecu tjelesne težine veće od 50 kg, te odrasle) Lakozamid Accord 50 mg filmom obložene tablete
• In this type of epilepsy, fits first affect only one side of your brain.
• U tom obliku epilepsije napadaji prvo zahvaćaju samo jednu stranu mozga, ali se nakon toga mogu proširiti i na veća područja zahvaćajući pritom obje strane mozga.
Depending on response and tolerability, the maintenance dose can be further increased by 2 mg/kg/day every week.
Ovisno o odgovoru i podnošljivosti, doza održavanja svakih tjedan dana može se dalje povećavati za 2 mg/kg/dan.
In all of these controlled studies, the discontinuation rate due to adverse reactions was 12.2 % for patients randomized to lacosamide and 1.6 % for patients randomized to placebo.
U svim navedenim kontroliranim ispitivanjima, stopa prekidanja liječenja zbog nuspojava bila je 12,2 % kod bolesnika randomiziranih na lakozamid i 1,6 % kod bolesnika randomiziranih na placebo.
Fall Skin laceration Contusion (1) Adverse reactions reported in post marketing experience.
Pad Laceracije kože Kontuzija (1) Nuspojave prijavljene u razdoblju nakon stavljanja lijeka u promet.
If you take more Lacosamide Accord than you should If you have taken more Lacosamide Accord than you should, contact your doctor immediately.
Ako ste uzeli više Lakozamid Accorda nego što ste smjeli, odmah se obratite liječniku.
In anesthetized dogs and Cynomolgus monkeys, at intravenous doses of 15-60 mg/kg, slowing of atrial and ventricular conductivity, atrioventricular block and atrioventricular dissociation were seen.
Nakon intravenskih doza od 15 do 60 mg/kg anesteziranim psima i makaki majmunima primijećeni su usporeno provođenje impulsa kroz atrij i ventrikul te atrioventrikularni blok i atrioventrikularna disocijacija.
This was reported with lacosamide in 4.8 % (3/62) in elderly patients versus 1.6 % (6/382) in younger adult patients.
Kod primjene lakozamida on je prijavljen u 4,8% (3/62) starijih bolesnika naspram 1,6% (6/382) u mlađih odraslih bolesnika.
Blood tests may show increased levels of liver enzymes and a type of white blood cell (eosinophilia); A widespread rash with blisters and peeling skin, particularly around the mouth, nose, eyes and genitals (Stevens-Johnson syndrome), and a more severe form causing skin peeling in more than 30 % of the body surface (toxic epidermal necrolysis);
• jako rasprostranjen osip s mjehurima i ljuštenjem kože, posebice oko usta, nosa, očiju i genitalija (Stevens-Johnsonov sindrom) te teži oblik koji uzrokuje ljuštenje kože na više od 30 % površine tijela (toksična epidermalna nekroliza);
• If your doctor decides to stop your treatment with Lacosamide Accord , they will tell you how to decrease the dose step by step.
• Ako liječnik odluči prekinuti Vaše liječenje Lakozamid Accordom, dat će Vam upute kako postupno smanjivati dozu.
Based on the analysis of pooled placebo-controlled clinical trials in adjunctive therapy in 1,308 patients with partial-onset seizures, a total of 61.9 % of patients randomized to lacosamide and 35.2 % of patients randomized to placebo reported at least 1 adverse reaction.
Na temelju analize udruženih placebom kontroliranih kliničkih istraživanja u dodatnoj terapiji u 1308 bolesnika s parcijalnim napadajima, ukupno 61,9 % bolesnika koji su randomizirani na lakozamid i 35,2 % bolesnika koji su randomizirani na placebo prijavilo je barem jednu nuspojavu.
During the second week, the patient takes Lacosamide Accord 100 mg tablets twice a day.
Tijekom drugog tjedna bolesnik uzima Lakozamid Accord tabletu 100 mg dvaput na dan.
• If you have missed a dose beyond the first 6 hours of the scheduled dose, do not take the missed tablet anymore.
• Ako je od propuštene doze proteklo više od 6 sati, nemojte uzimati propuštenu tabletu.
In this study, 425 patients aged 16 to 70 years with uncontrolled partial-onset seizures taking stable doses of 1 or 2 marketed antiepileptic medicinal products were randomized to be converted to lacosamide monotherapy (either 400mg/day or 300mg/day in a 3:1 ratio).
U tom je ispitivanju 425 bolesnika u dobi od 16 do 70 godina s nekontroliranim parcijalnim napadajima, koji su uzimali stabilne doze od 1 ili 2 antiepileptika dostupna na tržištu, randomizirano na prijelaz na monoterapiju lakozamidom (400 mg/dan ili 300 mg/dan u omjeru 3 : 1).
Convulsion.
• konvulzije.
14 film-coated tablets.
OBLIK I SADRŽAJ 14 filmom obloženih tableta.
When you take Lacosamide Accord with other antiepileptic medicines The usual starting dose of Lacosamide Accord is 50 mg twice a day.
Kad uzimate Lakozamid Accord s drugim antepileptičkim lijekovima Uobičajena je početna doza Lakozamid Accorda 50 mg dvaput na dan.
Lacosamide should be used with caution in patients with underlying proarrhythmic conditions such as patients with known cardiac conduction problems or severe cardiac disease (e.g. myocardial ischaemia/infarction, heart failure, structural heart disease or cardiac sodium channelopathies) or patients treated with medicinal products affecting cardiac conduction, including antiarrhythmics and sodium channel blocking antiepileptic medicinal products (see section 4.5), as well as in elderly patients.
Lakozamid treba oprezno primjenjivati kod bolesnika s podležećim proaritmijskim stanjima kao što su bolesnici s poznatim smetnjama provodljivosti srca ili teškom srčanom bolešću (npr. ishemija/infarkt miokarda, zatajenje srca, strukturna bolest srca ili srčane kanalopatije natrijskih kanala) ili bolesnika na terapiji lijekovima koji utječu na provodljivost srca, uključujući antiaritmike i antiepileptičke lijekove koji blokiraju natrijske kanale (vidjeti dio 4.5), te u starijih bolesnika.
Lacosamide Accord is indicated as monotherapy and adjunctive therapy in the treatment of partialonset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
Lakozamid Accord je indiciran kao monoterapija i dodatna terapija u liječenju parcijalnih napadaja sa sekundarnom generalizacijom ili bez nje u odraslih, adolescenata i djece od navršenih 4 godine života s epilepsijom.
Initiation of lacosamide treatment with a loading dose
Započinjanje liječenja lakozamidom udarnom dozom
Overall, the proportion of subjects with at least a 50 % reduction in partial-onset seizure frequency per 28 days from baseline to the maintenance period was 52.9 % in the lacosamide group compared with 33.3 % in the placebo group.
Ukupno je omjer ispitanika s barem 50 %-tnim smanjenjem djelomičnih pojava učestalosti napadaja od 28 dana od početne točke do razdoblja održavanja bio 52,9 % u skupini koja je primala lakozamid u usporedbi s 33,3 % u skupini koja je primala placebo.
• Sore throat (pharyngitis);
• upala grla (faringitis);
• medicines used to treat bacterial infections called clarithromycin or rifampicin;
• lijekovi koji se upotrebljavaju u liječenju bakterijskih infekcija zvani klaritromicin ili rifampicin;
• a herbal medicine used to treat mild anxiety and depression called St.John's wort
• biljni lijek koji se upotrebljava u liječenju blage tjeskobe i depresije zvan gospina trava
If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before taking Lacosamide Accord.
Ako se bilo koja od gornjih tvrdnji odnosi na Vas (ili niste sigurni u to), obratite se svom liječniku ili ljekarniku prije nego uzmete Lakozamid Accord.
This is because we do not yet know whether it will work and whether it is safe for children in this age group.
Lakozamid Accord se ne preporučuje za djecu mlađu od 4 godine zato što još nije poznato je li djelotvoran i siguran za djecu u toj dobnoj skupini.
Lacosamide Accord is indicated as monotherapy and adjunctive therapy in the treatment of partialonset seizures with or without secondary generalisation in adolescents and children from 4 years of age weighing 50 kg or more and in adults with epilepsy.
Lakozamid Accord je indiciran kao monoterapija i dodatna terapija u liječenju parcijalnih napadaja sa sekundarnom generalizacijom ili bez nje u adolescenata i djece od navršenih 4 godine života tjelesne težine 50 ili veće i u odraslih s epilepsijom.
• a herbal medicine used to treat mild anxiety and depression called St.John's wort.
• biljni lijek koji se upotrebljava u liječenju blage tjeskobe i depresije zvan gospina trava.
Film-coat: Polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide (E171), lecithin (soya) and colorants* * The colorants are
Film ovojnica: polivinilni alkohol, polietilenglikol, talk, titanijev dioksid (E171), lecitin (soja) i bojila* * Bojila su:
The percent reduction over placebo based on analysis of covariance was 31.72 % (95 % CI: 16.342, 44.277).
Postotno smanjenje u odnosu na analizu kovarijance temeljenu na placebu između lakozamida i placebo skupine bilo je 31,72 % (95 % CI: 16,342; 44,277).
The 14 x 1 or 56 x 1 tablet pack is available as perforated unit dose PVC-PVDC/Aluminium blisters sealed with an aluminium foil, all other packs are available with standard PVC-PVDC/Aluminium blisters sealed with an aluminium foil.
Pakiranja od 14 x 1 ili 56 x 1 tableta dostupna su u PVC-PVDC/aluminijskim perforiranim blisterima s jediničnim dozama, zatvorenim aluminijskom folijom.
Lacosamide Accord contains soya lecithin.
Lakozamid Accord sadrži sojin lecitin.
Accord Healthcare Ltd Sage House 319 Pinner Road North Harrow Middlesex
319 Pinner Road North Harrow
The estimated 6-month seizure freedom rates were 89.8 % for lacosamide-treated patients and 91.1 % for carbamazepine CR treated patients using the Kaplan-Meier survival analysis method.
Procijenjene stope bolesnika sa 6-mjesečnim razdobljem bez napadaja bile su 89,8% za bolesnike liječene lakozamidom i 91,1 % za bolesnike liječene karbamazepinom CR koristeći analizu po Kaplan-Meierovoj metodi.
Elevations of ALT to ≥3x ULN occurred in 0.7 % (7/935) of Lacosamide patients and 0 % (0/356) of placebo patients.
Povišene vrijednosti ALT-a do ≥ 3 x od gornje granice normale (GGN) zabilježene su u 0,7 % (7/935) bolesnika koji su uzimali lakozamid i u 0 % (0/356) bolesnika koji su uzimali placebo.
In adolescents and adults weighing 50 kg or more, a loading dose of 200 mg may be considered, but further dose titration (> 200 mg daily) should be performed with caution.
U adolescenata i u odraslih tjelesne težine 50 kg ili više može se razmotriti udarna doza od 200 mg, ali daljnju titraciju doze (>200 mg dnevno) treba provoditi s oprezom.
The administered lacosamide doses ranged from 2 to 17.8 mg/kg/day in twice daily intake, with a maximum of 600 mg/day for children weighing 50 kg or more.
Doze lakozamida davane su u rasponu od 2 do 17,8 mg/kg/dan dvaput na dan, s maksimalnom dozom od 600 mg/dan za djecu tjelesne od 50 kg ili više.
• If you have missed a dose within the first 6 hours of the scheduled dose, take it as soon as you remember.
• Ako primijetite da ste propustili dozu, a od propuštene doze je proteklo manje od 6 sati, dozu uzmite čim se sjetite.
The usual starting dose of Lacosamide Accord is 50 mg twice a day.
Uobičajena je početna doza Lakozamid Accorda 50 mg dvaput na dan.
Tablet core: Microcrystalline cellulose, hydroxy propyl cellulose-L, hydroxy propyl cellulose (low substituted), silica colloidal anhydrous, crospovidone and magnesium stearate.
Jezgra tablete: mikrokristalična celuloza, hidroksipropilceluloza-L, hidroksipropilceluloza (djelomično supstituirana), koloidni, bezvodni silicijev dioksid, krospovidon i magnezijev stearat.
If you weigh 50 kg or more, your doctor may decide to start Lacosamide Accord treatment with a single “loading” dose of 200 mg. You would then start your ongoing maintenance dose 12 hours later.
Ako je Vaša tjelesna težina 50 kg ili veća, Vaš liječnik može odlučiti započeti liječenje Lakozamid Accordom jednokratnom „udarnom“ dozom od 200 mg.
Also, it is not known whether Lacosamide Accord passes into the breast milk.
Također nije poznato izlučuje li se Lakozamid Accord u majčino mlijeko.
Based on the analysis of data from a non-inferiority monotherapy clinical trial comparing lacosamide to carbamazepine controlled release (CR), the most frequently reported adverse reactions (≥ 10 %) for lacosamide were headache and dizziness.
Na osnovi analize podataka iz kliničkog ispitivanja neinferiornosti monoterapije u kojem se lakozamid uspoređivao s karbamazepinom s kontroliranim oslobađanjem (engl. controlled release, CR), najčešće prijavljene nuspojave (≥ 10%) za lakozamid bile su glavobolja i omaglica.
LABORATORI FUNDACIÓ DAU C/ C, 12-14 Pol. Ind. Zona Franca, Barcelona, 08040 Barcelona, Spain or
Ind. Zona Franca, Barcelona, 08040 Barcelona, Španjolska ili
On the first day of treatment the patient starts with Lacosamide Accord 50 mg tablets twice a day.
Prvog dana liječenja bolesnik započinje s Lakozamid Accord tabletom od 50 mg dvaput na dan.
Polyvinyl alcohol
Lakozamid Accord s alkoholom
If you are taking Lacosamide Accord and you are experiencing symptoms of abnormal heartbeat (such as slow, rapid or irregular heartbeat, palpitations, shortness of breath, feeling lightheaded, fainting), seek medical advice immediately (see section 4).
Ako tijekom uzimanja Lakozamid Accorda primijetite simptome poremećaja otkucaja srca (kao što su usporeni, ubrzani ili nepravilni otkucaji srca, osjećaj lupanja srca, nedostatak zraka, osjećaj ošamućenosti, nesvjestica), odmah potražite liječničku pomoć (pogledajte dio 4).
The incidence rate for syncope reported in pooled adjunctive therapy clinical trials is uncommon and did not differ between lacosamide (n=944) treated epilepsy patients (0.1 %) and placebo (n=364) treated epilepsy patients (0.3 %).
Stopa incidencije sinkope zabilježena u združenim kliničkim ispitivanjima dodatne terapije manje je česta i nije se razlikovala između bolesnika s epilepsijom (n = 944) koji su liječeni lakozamidom (0,1%) i bolesnika s epilepsijom (n = 364) koji su dobivali placebo (0,3%).
Based on the analysis of data from a non-inferiority monotherapy clinical trial comparing lacosamide to carbamazepine controlled release (CR), the most frequently reported adverse reactions (≥10 %) for lacosamide were headache and dizziness.
Na osnovi analize podataka iz kliničkog ispitivanja neinferiornosti monoterapije u kojem se lakozamid uspoređivao s karbamazepinom s kontroliranim oslobađanjem (engl. controlled release, CR) najčešće prijavljene nuspojave (≥ 10%) za lakozamid bile su glavobolja i omaglica.
Packs of 14 x 1 or 56 x 1 tablet in perforated unit dose blisters Not all pack sizes may be marketed.
Pakiranja od 14 x 1 ili 56 x 1 tableta u perforiranim blisterima s jediničnim dozama
Other medicines and Lacosamide Accord
Drugi lijekovi i Lakozamid Accord
Based on data in adults, in paediatric patients weighing less than 50 kg with mild to moderate hepatic impairment, a reduction of 25 % of the maximum dose should be applied.
Na temelju podataka o odraslim bolesnicima, u pedijatrijskih bolesnika tjelesne težine manje od 50 kg s blagim do umjerenim oštećenjem jetre maksimalnu dozu treba smanjiti za 25 %.
Rash(1)
Osip(1)
In juvenile rats, a reduced body weight was observed at systemic exposure levels similar to the expected clinical exposure.
U mladunčadi štakora pri razinama sistemske izloženosti sličnim očekivanoj kliničkoj izloženosti zabilježeno je smanjenje tjelene težine.
In vitro data show that CYP2C9, CYP2C19 and CYP3A4 are capable of catalysing the formation of the Odesmethyl metabolite.
Podaci in vitro pokazuju da su CYP2C9, CYP2C19 i CYP3A4 sposobni katalizirati stvaranje
How to take Lacosamide Accord
Kako uzimati Lakozamid Accord
WESSLING Hungary Kft, Anonymus u. 6., Budapest, 1045, Hungary or
6., Budapest , Mađarska ili
The AUC of lacosamide was increased by approximately 30% in mildly and moderately and 60% in severely renal impaired patients and patients with end-stage renal disease requiring haemodialysis compared to healthy subjects, whereas Cmax was unaffected.
AUC lakozamida bio je, u usporedbi sa zdravim ispitanicima, povećan za oko 30 % u bolesnika sa blagim i umjerenim oštećenjem bubrega te za 60 % u bolesnika s teškim oštećenjem bubrega i u bolesnika sa završnim stadijem bubrežne bolesti koji zahtijevaju hemodijalizu, dok je Cmax bio nepromijenjen.
Paediatric population Adolescents and children weighing 50 kg or more
Pedijatrijska populacija Adolescenti i djeca tjelesne težine 50 kg ili više
What Lacosamide Accord is used for
Za što se Lakozamid Accord koristi
Adolescents and children weighing 50 kg or more and adults When you take Lacosamide Accord on its own
Adolescenti i djeca tjelesne težine 50 kg ili više i odrasli Kad uzimate samo Lakozamid Accord
In paediatric patients weighing 50 kg or more and in adult patients with severe renal impairment (CLCR ≤30 ml/min) or with end-stage renal disease, a maximum dose of 250 mg/day is recommended and the dose titration should be performed with caution.
U pedijatrijskih bolesnika tjelesne težine 50 kg ili više i u odraslih bolesnika s teškim oštećenjem bubrega (CLCR ≤ 30 ml/min) ili sa završnim stadijem bubrežne bolesti preporučuje se maksimalna doza od 250 mg/dan, a titraciju doze mora se provesti s oprezom.
• You have been given this medicine to lower the number of fits (seizures) you have.
• Ovaj Vam je lijek dan za smanjenje broja napadaja.
Each pack of 56 film-coated tablets for a 4-week treatment schedule contains: 14 film-coated tablets of Lacosamide Accord 50 mg 14 film-coated tablets of Lacosamide Accord 100 mg 14 film-coated tablets of Lacosamide Accord 150 mg 14 film-coated tablets of Lacosamide Accord 200 mg
Svako pakiranje s 56 filmom obloženih tableta za program 4-tjednog liječenja sadrži: 14 filmom obloženih tableta Lakozamid Accord 50 mg 14 filmom obloženih tableta Lakozamid Accord 100 mg 14 filmom obloženih tableta Lakozamid Accord 150 mg 14 filmom obloženih tableta Lakozamid Accord 200 mg
Magnesium stearate
Poremećaji hodanja Astenija
A single loading dose of 200 mg approximates steady-state concentrations comparable to 100 mg twice daily oral administration.
Postizanje koncentracija u stanju dinamičke ravnoteže kod jednokratne udarne doze od 200 mg usporedivo je s koncentracijama kod peroralne primjene 100 mg dvaput dnevno.
Microcrystalline cellulose Hydroxy propyl cellulose-L Hydroxy propyl cellulose (low substituted) Silica, colloidal, anhydrous Crospovidone
Jezgra tablete celuloza, mikrokristalična hidroksipropilceluloza-L hidroksipropilceluloza (djelomično supstituirana) silicijev dioksid, koloidni, bezvodni krospovidon magnezijev stearat
Lacosamide Accord 200 mg
Lakozamid Accord 200 mg
Lacosamide Accord 150 mg
Lakozamid Accord 150 mg
The oral bioavailability of lacosamide tablets is approximately 100%.
Bioraspoloživost lakozamida nakon peroralne primjene je otprilike 100 %.
QUALITATIVE AND QUANTITATIVE COMPOSITION Lacosamide Accord 50 mg film-coated tablets One film-coated tablet contains 50 mg lacosamide.
KVALITATIVNI I KVANTITATIVNI SASTAV Lakozamid Accord 50 mg filmom obložene tablete Jedna filmom obložena tableta sadrži 50 mg lakozamida.
Lacosamide Accord 50 mg
Lakozamid Accord 50 mg
Maximum recommended dose in patients < 40 kg up to 12 mg/kg/day Maximum recommended dose in patients ≥ 40 kg to < 50 kg up to 10 mg/kg/day
2 mg/kg/dan svakih tjedan dana Maksimalna preporučena doza u bolesnika < 40 kg do 12 mg/kg/dan Maksimalna preporučena doza u bolesnika ≥ 40 kg do < 50 kg do 10 mg/kg/dan
What Lacosamide Accord looks like and contents of the pack Lacosamide Accord 50 mg are pink, oval, approximately 10.3 x 4.8 mm, coated tablets, debossed “L” on one side and “50” on other side.
Kako Lakozamid Accord izgleda i sadržaj pakiranja Lakozamid Accord 50 mg su ružičaste, ovalne filmom obložene tablete približne veličine od 10,3 x 4,8 mm s utisnutom oznakom „L“ na jednoj strani i „50“ na drugoj strani.
the package marked ‘Week 3' contains 14 tablets of 150 mg, the package marked ‘Week 4' contains 14 tablets of 200 mg .
• Pakiranje označeno '4.tjedan ' sadrži 14 tableta od 200 mg.
Adolescents and children weighing 50 kg or more
Adolescenti i djeca tjelesne težine 50 kg ili više
OTHER Week 1
DRUGO 1.tjedan
Liver function test abnormal (2)
Promijenjeni nalazi jetrene funkcije(2)
Taking Lacosamide Accord
Uzimanje Lakozamid Accorda
Lacosamide Accord 100 mg
Lakozamid Accord 100 mg
150 mg (1 tablet Lacosamide Accord 150 mg)
150 mg (1 tableta Lakozamid Accord 150 mg)
One tablet of Lacosamide Accord 200 mg contains 200 mg lacosamide.
Jedna tableta Lakozamid Accord 200 mg sadrži 200 mg lakozamida.
Adolescents and children weighing 50 kg or more, and adults Monotherapy
Adolescenti i djeca tjelesne težine 50 kg ili više, te odrasli Monoterapija
Blood tests may show a severe decrease in a specific class of white blood cells (agranulocytosis); A serious skin reaction which may include a high temperature and other flu-like symptoms, a rash on the face, extended rash, swollen glands (enlarged lymph nodes).
• ozbiljna kožna reakcija koja može uključivati visoku tjelesnu temperaturu i druge simptome nalik gripi, osip po licu, osip koji se širi , otečene žlijezde (povećani limfni čvorovi).
150 mg tablet: Iron oxide red (E172), iron oxide black (E172), iron oxide yellow (E172) 200 mg tablet: Indigo carmine aluminum lake (E132)
150 mg tableta: crveni željezov oksid (E172), crni željezov oksid (E172), žuti željezov oksid (E172) 200 mg tableta: indigo karmin aluminium lake (E132)
200 mg (1 tablet Lacosamide Accord 200 mg)
200 mg (1 tableta Lakozamid Accord 200 mg)
• medicines which can increase the “PR interval” on a scan of the heart (ECG or electrocardiogram) such as medicines for epilepsy or pain called carbamazepine, lamotrigine or pregabalin;
EKG) kao što su lijekovi za liječenje epilepsije ili ublažavanje bolova zvani karbamazepin,
OTHER Week 2
DRUGO 2. tjedan
One tablet of Lacosamide Accord 100 mg contains 100 mg lacosamide.
Jedna tableta Lakozamid Accord 100 mg sadrži 100 mg lakozamida.
One tablet of Lacosamide Accord 50 mg contains 50 mg lacosamide.
Jedna tableta Lakozamid Accord 50 mg sadrži 50 mg lakozamida.
One tablet of Lacosamide Accord 150 mg contains 150 mg lacosamide.
Jedna tableta Lakozamid Accord 150 mg sadrži 150 mg lakozamida.
Laboratori Fundacio Dau C/ C, 12-14 Pol. Ind. Zona Franca 08040 Barcelona SPAIN
Laboratori Fundacio Dau C/ C, 12-14 Pol.
50 mg (1 tablet Lacosamide Accord 50 mg)
50 mg (1 tableta Lakozamid Accord 50 mg)
Lacosamide Accord 200 mg are blue, oval, approximately 16.4 x 7.6 mm, coated tablets, debossed “L” on one side and “200” on other side.
Lakozamid Accord 200 mg su plave, ovalne filmom obložene tablete približne veličine od 16,4 x 7,6 mm s utisnutom oznakom „L“ na jednoij strani i „200“ na drugoj strani.
Lacosamide Accord 50 mg Lacosamide Accord 100 mg Lacosamide Accord 150 mg Lacosamide Accord 200 mg
Lakozamid Accord 50 mg Lakozamid Accord 100 mg Lakozamid Accord 150 mg Lakozamid Accord 200 mg
WESSLING Hungary Kft, Anonymus u. 6., Budapest, 1045, Hungary
WESSLING Hungary Kft, Anonymus u.
100 mg (1 tablet Lacosamide Accord 100 mg)
100 mg (1 tableta Lakozamid Accord 100 mg)
Pink, oval, approximately 10.3 x 4.8 mm, coated tablets, debossed “L” on one side and “50” on other side.
Ružičaste, ovalne filmom obložene tablete približne veličine 10,3 x 4,8 mm s utisnutom oznakom„L“ na jednoj strani i „50“ na drugoj strani.
OTHER Week 4
DRUGO 4. tjedan
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS TREATMENT INITIATION PACK ONLY Blister label - week 3
LIJEČENJA PODACI KOJE MORA NAJMANJE SADRŽAVATI BLISTER ILI STRIP Blister - 4. tjedan
Lacosamide Accord 100 mg film coated tablets: EU/1/17/1230/005-008
Lakozamid Accord 100 mg filmom obložene tablete EU/1/17/1230/005-008